Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
MCL1 is essential for the survival of stem and progenitor cells of multiple lineages, and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases. B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse. The mechanism of MCL1 overexpression in cancer is not well understood. Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival. USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degradation. Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas. Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis. Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737. These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phosphorylation of MCL1 at S159 and T163 also affects the USP9X-MCL1 interaction [121].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [121]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Self-citationThe molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,006
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Zhong, Q., Gao, W., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.06.009 · Cited by 842
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Cited by
Items 601–630 of 630
Molecular basis of BCL2L10/Nrh oncogenic activity in breast cancer
Nougarède, A. (2016) · theses.fr (ABES) · doi:10.70675/67283ec1z7040z4d6eza688z407667ae770d
Régulation de la stabilité de la protéine anti-apoptotique BCL2A1
Lionnard, L. (2018) · theses.fr (ABES) · doi:10.70675/1eec02ffz98dez4a56z98e2z389a2cd8558d
Étude mécanistique de la fibrose interstitielle rénale et essai de preuve de concept thérapeutique
Gaillard, F. (2018) · theses.fr (ABES) · doi:10.70675/72e11c14zcc9fz4acdzbb83z2368f5351848 · Cited by 1
Boulch, M. L. (2019) · theses.fr (ABES) · doi:10.70675/801dbbc1z6df7z4b22z996bz353e41479c93
Louault, K. (2018) · theses.fr (ABES) · doi:10.70675/0aef1137z5689z4922z8455zdbe4b757612c
Caractérisation et études précliniques d'un nouvel inhibiteur naturel de MCL-1
Daressy, F. (2020) · theses.fr (ABES) · doi:10.70675/4e4153f4zba2dz49bcz9862z38251f3f7882
Bcl2L10 : polymorphisme, résistance oncogénique et conséquences thérapeutique dans le cancer du sein
Quang, D. M. (2021) · theses.fr (ABES) · doi:10.70675/86dd7fafzcb40z4cedz8eb7zbb41268cd809
Mitochondrial Ubiquitination as a Signaling Hub: Balancing Mitophagy, Inflammation, and Cell Death
Kumar, A. P., & Zacharioudakis, E. (2026) · Biochemistry · doi:10.1021/acs.biochem.6c00007 · Cited by 2
Bou‐Rouphael, J. (2023) · theses.fr (ABES) · doi:10.70675/92bff1fez5902z44f2za52azed6b0b92fad4
USP9X promotes the degradation of trapped translation factors on collided ribosomesPreprint
Teodorowicz, W., Gurzeler, L., & Mühlemann, O. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.23.720364
Ubiquitin-specific proteases in ovarian cancer: molecular mechanisms and therapeutic implications
Deng, L., Jiang, Y., Wang, D., Yu, J., & Wu, L. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02138-2
Zheng, Z., Wang, Y., Zhou, D., Zhang, H., Kong, L., Fan, S., Ji, X., 宗文哲, An, X., Liu, Z., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9542123/v1
Zhang, J., Liu, J., Zhao, M., Zhang, X., Liu, L., Li, M., Cao, C., Zhang, R., & Zhao, M. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70797 · Cited by 1
Self-citationDabur, R. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70297
Jin, R., Ni, R., Ding, N., Tao, Y., Cai, S., Shi, Y., Liu, M., Chen, Y., Yu, L., & Lü, J. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl51975
Choi, M., & Baek, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188049
Wang, Y., & Shi, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1933967
USP9X promotes the degradation of trapped translation factors on collided ribosomes
Teodorowicz, W., Gurzeler, L.-A., & Mühlemann, O. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118125
Ito, Y., Nakagawa-Saito, Y., Nakamura, K., Suzuki, S., Mitobe, Y., Takenouchi, S., Togashi, K., Sugai, A., Seino, M., Ohta, T., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209261
BindingDB Entry 50016046: Development of Mcl-1 inhibitors for cancer therapy.
BindingDB (2023) · UC San Diego · doi:10.7270/q2b28081
BindingDB (2024) · UC San Diego · doi:10.7270/q2t72nnm
Targeting Apoptotic Pathways in Melanoma
Hersey, P., & Zhang, X. D. (2011) · Springer eBooks · doi:10.1007/978-1-61779-407-0_9
Investigating the anti-apoptotic role of EBV in endemic Burkitt lymphona
Fitzsimmons, L. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Metadata
- Authors
- Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., Yue, P., Dornan, D., Huang, D. C. S., & Dixit, V. M.
- Affiliations
- Genentech (US)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Corresponding author
- Dixit, Vishva M.
- Venue
- Nature
- Published
- 2009-12-20
- Volume
- 463
- Issue
- 7277
- Pages
- 103-107
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991249033
- Cited by
- 628
- References
- 31
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 20 · 2023: 21 · 2022: 20 · 2021: 38 · 2020: 41 · 2019: 44 · 2018: 45 · 2017: 45 · 2016: 51 · 2015: 49 · 2014: 50 · 2013: 46 · 2012: 44
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- USP9X, Mcl-1, deubiquitinase, protein stabilization, ubiquitination, multiple myeloma, Bcl-2 family proteins, apoptosis, ABT-737, BH3 mimetics, follicular lymphoma, diffuse large B-cell lymphoma, chemoresistance, therapeutic target, prognosis, proteasomal degradation, stem/progenitor cells, tumor cell survival
- MeSH terms
- Docetaxel, Animals, Biphenyl Compounds, Cell Line, Cell Survival, DNA Damage, Etoposide, Female, Half-Life, Humans, Lysine, Neoplasms, Nitrophenols, Phosphorylation, Piperazines, Prognosis, Protein Binding, Sulfonamides, Ultraviolet Rays, Gene Expression Regulation, Neoplastic, Mice, SCID, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Xenograft Model Antitumor Assays, Polyubiquitin, RNA Interference, Ubiquitin Thiolesterase, Taxoids, Cell Line, Tumor, Mice, Ubiquitination, Protein Stability, Gene Knockdown Techniques, Myeloid Cell Leukemia Sequence 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.